News

elegslab Signs Multi-Party MOU with Woojung Bio for Next-Gen Drug Discovery Platform
2025-06-17

Woojung Bio has entered a multi-party MOU with partners including elegslab (In vivo ADME & Efficacy Evaluation alternative testing platform).

http://www.hitnews.co.kr

https://weekly.hankooki.com/news/articleView.html?idxno=7115654

https://www.biotimes.co.kr/news/articleView.html?idxno=22039

https://www.mk.co.kr/news/it/11345046

Get a 1:1 consultation with elegslab today.

Contact us, and we’ll get back to you within 3 business days.
Contact Us